Karuna Therapeutics Entered into an Exclusive License Agreement with Goldfinch Bio for TRPC4/5 Product Candidates
Shots: Goldfinch Bio will receive $15M up front & is eligible to receive ~$520...
Shots: Goldfinch Bio will receive $15M up front & is eligible to receive ~$520...
Shots: Orbit & Endevica Bio collaborated to advance the development of cachexi...
Shots: Apic Bio to receive $10M up front & is also eligible to receive ~$45M i...
Shots: The companies will jointly develop, clinically validate & adopt Galen B...
Shots: HK inno.N collaborated with mAbxience for a denosumab biosimilar referencin...
Shots: The companies collaborated to commercialize two cancer supportive care prod...
Incisive News in 3 Shots.